HRP20020703B1 - Memno peptides, a process for their preparation and their use - Google Patents

Memno peptides, a process for their preparation and their use

Info

Publication number
HRP20020703B1
HRP20020703B1 HR20020703A HRP20020703A HRP20020703B1 HR P20020703 B1 HRP20020703 B1 HR P20020703B1 HR 20020703 A HR20020703 A HR 20020703A HR P20020703 A HRP20020703 A HR P20020703A HR P20020703 B1 HRP20020703 B1 HR P20020703B1
Authority
HR
Croatia
Prior art keywords
formula
group
alkyl
hydrogen atom
atom
Prior art date
Application number
HR20020703A
Other languages
English (en)
Croatian (hr)
Inventor
Vertesy Laszlo
Kogler Herbert
Markus Astrid
Schiell Matthias
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20020703A2 publication Critical patent/HRP20020703A2/hr
Publication of HRP20020703B1 publication Critical patent/HRP20020703B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20020703A 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use HRP20020703B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001661 WO2001064715A2 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Publications (2)

Publication Number Publication Date
HRP20020703A2 HRP20020703A2 (en) 2004-12-31
HRP20020703B1 true HRP20020703B1 (en) 2011-01-31

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020703A HRP20020703B1 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Country Status (30)

Country Link
US (1) US6627604B2 (cs)
EP (2) EP1130027A1 (cs)
JP (1) JP4787449B2 (cs)
KR (1) KR100997073B1 (cs)
CN (1) CN1274715C (cs)
AR (1) AR029808A1 (cs)
AT (1) ATE313556T1 (cs)
AU (2) AU5031801A (cs)
BR (1) BR0108757A (cs)
CA (1) CA2401032C (cs)
CY (1) CY1105550T1 (cs)
CZ (1) CZ303552B6 (cs)
DE (1) DE60116063T2 (cs)
DK (1) DK1261625T3 (cs)
EE (1) EE05406B1 (cs)
ES (1) ES2254394T3 (cs)
HK (1) HK1052712B (cs)
HR (1) HRP20020703B1 (cs)
HU (1) HU228067B1 (cs)
IL (2) IL151458A0 (cs)
ME (1) MEP59108A (cs)
MX (1) MXPA02007845A (cs)
NO (1) NO329082B1 (cs)
NZ (1) NZ521036A (cs)
PL (1) PL206818B1 (cs)
RU (1) RU2261254C2 (cs)
SI (1) SI1261625T1 (cs)
SK (1) SK287310B6 (cs)
WO (1) WO2001064715A2 (cs)
ZA (1) ZA200206841B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
US11030144B2 (en) * 2018-12-14 2021-06-08 Texas Instruments Incorporated Peripheral component interconnect (PCI) backplane connectivity system on chip (SoC)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
RU2083585C1 (ru) * 1994-12-13 1997-07-10 Волгоградское акционерное общество открытого типа "Химпром" Способ получения метилового эфира n-бензилоксикарбонил-l-аспартил-l-фенилаланина
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1038008B1 (en) * 1997-12-16 2006-10-18 Genencor International, Inc. Methods for producing egiii-like enzymes
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
CY1105550T1 (el) 2010-07-28
BR0108757A (pt) 2002-12-10
EE200200480A (et) 2004-02-16
ME00379B (me) 2011-05-10
CA2401032A1 (en) 2001-09-07
EP1130027A1 (de) 2001-09-05
US20010031857A1 (en) 2001-10-18
IL151458A0 (en) 2003-04-10
NO329082B1 (no) 2010-08-16
HU228067B1 (en) 2012-09-28
ZA200206841B (en) 2003-07-03
ES2254394T3 (es) 2006-06-16
CN1274715C (zh) 2006-09-13
MXPA02007845A (es) 2002-11-29
JP2004512257A (ja) 2004-04-22
CZ20022904A3 (cs) 2002-11-13
PL358300A1 (en) 2004-08-09
AR029808A1 (es) 2003-07-16
HUP0204584A2 (hu) 2003-04-28
HK1052712B (zh) 2007-01-12
HUP0204584A3 (en) 2005-09-28
JP4787449B2 (ja) 2011-10-05
EP1261625A2 (en) 2002-12-04
US6627604B2 (en) 2003-09-30
RU2261254C2 (ru) 2005-09-27
NO20024105L (no) 2002-10-28
MEP59108A (en) 2011-05-10
SK287310B6 (sk) 2010-06-07
CA2401032C (en) 2012-04-10
ATE313556T1 (de) 2006-01-15
WO2001064715A3 (en) 2002-03-21
WO2001064715A2 (en) 2001-09-07
AU2001250318B2 (en) 2005-09-08
AU5031801A (en) 2001-09-12
CZ303552B6 (cs) 2012-12-05
DK1261625T3 (da) 2006-04-18
DE60116063T2 (de) 2006-08-03
EP1261625B1 (en) 2005-12-21
RU2002125877A (ru) 2004-01-10
HRP20020703A2 (en) 2004-12-31
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
CN1406243A (zh) 2003-03-26
NZ521036A (en) 2004-02-27
EE05406B1 (et) 2011-04-15
SI1261625T1 (sl) 2006-04-30
HK1052712A1 (en) 2003-09-26
DE60116063D1 (de) 2006-01-26
IL151458A (en) 2008-08-07
PL206818B1 (pl) 2010-09-30
SK12262002A3 (sk) 2003-02-04
KR100997073B1 (ko) 2010-11-30

Similar Documents

Publication Publication Date Title
NO20041494L (no) Nye ligander for HisB 10 Zn2+ -setene i insulinheksameren i R-form
CR7080A (es) Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
DK0715628T3 (da) Substituerede azaindolyliden-forbindelser og fremgangsmåde til fremstilling deraf
TW200500383A (en) Mixtures of compounds having two or more double bonds and use thereof
PA8439101A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
DK1086124T3 (da) Nye cyclosporiner
AU2003257302A1 (en) Phosphonium and imidazolium salts and methods of their preparation
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
ES8705469A1 (es) Procedimiento para preparar nuevas somatostatinas
HRP20020703B1 (en) Memno peptides, a process for their preparation and their use
ES8502106A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
HRP20050361B1 (hr) Novi postupak za industrijsku sintezu tetraestera 5-[bis(karboksimetil)amino]-3-karboksimetil-4-cijano-2-tiofenkarboksilne kiseline i njihova primjena u sintezi bivalentnih soli ranelinske kiseline i njihovih hidrata
HRP20050390A2 (en) Substituted benzoxazinones and uses thereof
IL158324A0 (en) Arylsulphonamides as anttiviral agents
CO4761058A1 (es) Nuevos derivados de benzoilguanidina, procedimientos para su preparacion y su utilizacion en la preparacion de medicamentos
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
WO1998045394A3 (en) Composition useful for fabric softening applications and processes for the preparation thereof
DK0649312T3 (da) Anthracyclinkonjugater, deres fremstilling og deres anvendelse som antitumormidler
ATE239034T1 (de) Mechanismus-orientierte inhibitoren der dipeptidylpeptidase i
BG106117A (en) Novel 8a- and 9a-15-membered lactams
UA41348C2 (uk) Проліки 3-ацил-2-оксіндол-1-карбоксамідів та фармацевтична композиція

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170111

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20180215